Dataset

Immune response to mRNA vaccine doses in SARS-CoV-2 infection naïve nursing home residents and staff (PICOV-VAC)

A collection of data (lab analysis and surveys) from a Belgian cohort of staff and residents of nursing homes, subsample of the PICOV study. Data are about participants' immunity previous and after COVID-19 vaccination (dose 1 , 2 and 3) using mRNA COVID-19 vaccine BTB162b2. Adverse events linked to the vaccination are available. Participants' survey with their health status is also available.

Overview

Keywords
COVID-19 Adverse events Elderly people Immunology Nursing home Vulnerable population
Languages
en
Health Categories
Data from clinical trials, clinical studies and clinical investigations subject to Regulation (EU) 536/2014, Regulation [SOHO], Regulation (EU) 2017/745 and Regulation (EU) 2017/746, respectively
Population Coverage
Staff and nursing home residents
Provenance
  • Pseudonymised dataset, ethical approval granted
Documentation

Temporal Information

Temporal Coverage
Start
End
Update Frequency
NEVER
Metadata Dates
Issued:
Modified:

Spatial Information

Geographic Coverage
  • BE
NUTS Codes
http://data.europa.eu/nuts/code/BE

Additional Information

Dataset Types
Personal Data
Applicable Legislation
Legal Basis

  • Clinical Trial Regulation

    Source
HDAB
Contact Points
Conforms To
Structured Identifiers

Distributions & Resources

HDA request form

https://www.hda.belgium.be/en/data-request-form

Restricted en
Publication Info
License cc-zero1.0
Standards & Languages
Languages en
Conforms To
Distribution Profile
Direct Links
Access URL https://www.hda.belgium.be/en/data-request-form
COVID-19
Adverse events
Elderly people
Immunology
Nursing home
Vulnerable population